About the Company
spectrum's core mission is to bring pharmaceutical products to patients for unmet medical needs. to this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. spectrum and its subsidiaries have six marketed oncology/hematology products, three for different types of non-hodgkins lymphoma, one for advanced metastatic colorectal cancer, one for a certain type of acute lymphoblastic leukemia (all) and one for multiple myeloma. there are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a focus on oncology and hematology.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SPPI News
Spectrum Pharmaceuticals gets grant for crystalline form of quinazoline compound and hydrochloride salts
Discover the groundbreaking patent granted to Spectrum Pharmaceuticals Inc for a quinazoline compound, its crystalline forms, and hydrochloride salts. Learn about the innovative preparation method, ...
OC Drugmakers Cut Headcounts, Close Offices
The Business Journal’s annual listing of the largest local players in the pharmaceutical industry shows a sector that remains ...
MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why
Inc. MNMD have skyrocketed 154% in the past three months against the industry’s decline of 4.2%. The company is progressing ...
Non-Hodgkin Lymphoma Pipeline Landscape 2024: Analysis of Over 220 Potential Pharmaceuticals in Development
Hodgkin Lymphoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A new comprehensive report has emerged, offering in-depth insights into the future of Non-Hodgkin ...
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
Q1 2024 net product revenue of $78.9 million, representing 85% year-over-year growth –– ARCALYST 2024 expected net ...
Global Equine Veterinary Therapeutics Industry
Global Equine Veterinary Therapeutics Industry is projected to reach a valuation of US$ 485.1 Mn in 2022, surge at a 5.7% ...
Constellation Pharmaceuticals gets grant for novel compounds for treating diseases associated with methyl modifying enzymes
Discover how Constellation Pharmaceuticals Inc's patented compounds are revolutionizing cancer treatment. Learn about the versatile applications and potential for treating various types of cancer.
The Best Ashwagandha Supplements, According to Health Experts
Ashwagandha is touted to reduce stress and anxiety, boost focus, and improve sleep. Here are our favorite options.
Baron Focused Growth Fund Q1 2024 Shareholder Letter
Baron Focused Growth Fund increased 1.68% in the first quarter. The Fund underperformed the Russell 2500 Growth Index (the ...
Polaris Global Equity Composite Q1 2024 Commentary
Global equity markets enjoyed consecutive months of gains, with the MSCI World Index returning 9.01% for the quarter.
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes ...
Cannabisnewsbreaks Inmed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority In Alzheimer's Research To Scientific Advisory Board
InMed Pharmaceuticals (NASDAQ: INM) , a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabin ...
Loading the latest forecasts...